Abstract:Epidermal growth factor (EGF) signaling and Hedgehog (HH) signaling are both involved in prostate cancer (PCa) progression, yet the mechanisms through which these two pathways are synergistically linked require elucidation. In the present study, we aimed to ascertain how EGF and the HH signaling transcription factor GLI-1 are linked in prostate cancer invasiveness. ARCaP human prostate cancer cells, which included ARCaP(E) and ARCaP(M) cells, were used as a model in the present study. The expression of EGF receptor (EGFR) and the HH signaling transcriptional factor GLI-1 were detected in ARCaP(E) cells by immunofluorescence, and the ARCaP(E) cells were treated with human recombinant EGF protein (hrEGF) for 4 consecutive days in vitro. Transwell invasion assays were performed in the ARCaP(E) cells following treatment with DMSO (vehicle control), hrEGF, GATN61 (GLI-1-specific inhibitor), hrEGF plus GANT61 and in the ARCaP(M) cells. The expression of phosphorylated extracellular signal regulated kinase (p-ERK), total ERK and GLI-1 was detected by western blotting in ARCaP(E) cells at different time-points following treatment with hrEGF. The expression of EGFR and GLI-1 was detected in ARCaP(E) cells, which exhibited a cobblestone-like morphology, while after treatment with hrEGF, the cell morphology was altered to a spindle-shaped mesenchymal cell morphology. Transwell invasion assays demonstrated that hrEGF dramatically enhanced the invasive capability of the ARCaP(E) cells (P<0.05). Additionally, western blot assay demonstrated that the expression levels of p-ERK and GLI-1 in ARCaP(E) cells increased in a time-dependent manner after treatment with hrEGF (P<0.05); however, the expression levels of total ERK in the cells remained relatively unchanged. It also demonstrated that the GLI-1 inhibitor GANT61 could reverse the enhanced invasive effect induced by EGF in ARCaP(E) cells (P<0.05). Our preliminary in vitro study showed that EGF signaling may increase the invasive capability of ARCaP(E) human prostate cancer cells via upregulation of p-ERK and the HH signaling transcriptional factor GLI-1. Additionally, this enhanced cell invasive effect was reversed by a GLI-1-specific inhibitor in vitro. Consequently, it indicates that both EGF and HH signaling are synergistically involved in the progression of human prostate cancer ARCaP cells, and GLI-1 may be one of the important effectors, which is activated by EGF downstream signaling, to promote the invasiveness of ARCaP(E) prostate cancer cells.

Epidermal growth factor enhances MPC-83 pancreatic cancer cell migration through the upregulation of aquaporin 3.

Down-Regulation Of Gep100 Causes Increase In E-Cadherin Levels And Inhibits Pancreatic Cancer Cell Invasion

Identification of Estrogen Response Element in Aquaporin-3 Gene that Mediates Estrogen-induced Cell Migration and Invasion in Estrogen Receptor-positive Breast Cancer

Correction: EGFR-mediated Expression of Aquaporin-3 is Involved in Human Skin Fibroblast Migration.

Epidermal Growth Factor Promotes Invasiveness of Pancreatic Cancer Cells Through Nf-Kappa B-Mediated Proteinase Productions

Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells

Aquaporin3 Is Required For Fgf-2-Induced Migration Of Human Breast Cancers

The Effect of Epidermal Growth Factor Receptor Variant III on Glioma Cell Migration by Stimulating ERK Phosphorylation Through the Focal Adhesion Kinase Signaling Pathway

EPCR Promotes MGC803 Human Gastric Cancer Cell Tumor Angiogenesis in Vitro Through Activating ERK1/2 and AKT in a PAR1-dependent Manner.

ERas Regulates Cell Proliferation and Epithelial–mesenchymal Transition by Affecting Erk/Akt Signaling Pathway in Pancreatic Cancer

Curcumin down-regulates AQP3 and AQP3-mediated cell migration by inhibiting EGFR activation in ovarian cancer cells

Epidermal growth factormediated nuclear factor kappa B activation induces urokinase plasminogen activator expression and invasion,metastasis of pancreatic cancer cells

[Epidermal Growth Factor Up-Regulates the Mrna Expression of Endothelin-1 and Its Receptors in Prostate Cancer PC-3 Cell Lines].

Endocrine gland‑derived vascular endothelial growth factor modulates proliferation, apoptosis and migration in pancreatic cancer cells.

Role of Epidermal Growth Factor in Invasion and Metastasis of Pancreatic Cancer Cells

Epidermal Growth Factor-Mediated NF-κB Activity Induces Matrix Metalloproteinase-9 Expression and Invasion in Pancreatic Cancer Cell

Glypican-3 Promotes Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells Through Erk Signaling Pathway

Response Gene To Complement-32 Mediates Tgf-Beta-Induced Epithelial-Mesenchymal Transition Via Erk-/P38-Mapk Signaling Pathways In Human Pancreatic Cancer Cell Line Bxpc-3

Endocrine Glands-Derived Vascular Endothelial Growth Factor Protects Pancreatic Cancer Cells from Apoptosis Via Upregulation of the Myeloid Cell Leukemia-1 Protein

Role of GLI-1 in Epidermal Growth Factor-Induced Invasiveness of ARCaP(E) Prostate Cancer Cells

Requirement of the epidermal growth factor receptor in renal epithelial cell proliferation and migration.